Find and Pitch Jounalists, Get Your Story Covered

Tags: Contemporary art A brush with...podcast Artist interview Artists Shahzia Sikander

	Profile	Recent Articles on Subject
1	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 days ago
2	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 6 days ago STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 6 days ago The news from ESMO: The latest on anti-TIGIT data, a PD-(L)1 injection, and more - 6 days ago STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer - 11 months ago STAT+: What to watch at ESMO: readouts from trials in lung, prostate, and other types of cancer - 11 months ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - 6 days ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 7 days ago Key Market Trends for the Current Specialty Drug Pipeline - 11 months ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Nxera and Cancer Research UK to present promising cancer drug trial at ESMO - 7 days ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids - 7 days ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 14 days ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids - 7 days ago STAT+: Can iTeos and GSK solve TIGIT’s troubles? - 8 days ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 14 days ago STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal - 15 days ago STAT Virtual Event \| Cancer’s Breakthrough Engine - 9 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids - 7 days ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 14 days ago STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - about 2 months ago
9	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: U.K. charities give $36 million to start new drugs for childhood tumors - 15 days ago STAT+: Gritstone Bio says personalized cancer vaccine falls short in key trial - 6 months ago
10	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Transforming Cancer Care: Innovations in Immunotherapy and the Critical Role of the Pharmacist - about 1 month ago

Journalists covering Brush-up Summaries, cancer research, drug development, immunology